Renewed interest from the biotech industry sparks hope for drugging the nucleic acid to treat cancer and other conditions.

Decades after their discovery by bioprospectors, amphibian-derived analgesics continue to attract scientific attention.

If successful, the treatments could alleviate patients’ pain by reducing inflammation.

Compounds in the arachnids’ venom interact with ion channels to both cause and block pain.

In tiny doses, the pufferfish’s tetrodotoxin can be turned into a pain-relieving ion channel blocker.

Arachnids harbor a plentiful array of molecules that target mammalian pain receptors.

Venomous centipedes may harbor a clue to the creation of a successful pain-killing compound for humans.

Studying cone snail venom has yielded novel pain pathways, but the peptides that function as toxins are difficult to translate into drugs.

Painful snake bites may hold clues to developing analgesic drugs.